|
FY2026
12 months to Jan 3, 2026
|
FY2025
12 months to Dec 28, 2024
|
FY2024
12 months to Dec 30, 2023
|
FY2023
12 months to Dec 31, 2022
|
FY2022
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| (Gain) on sale of business | |||||
| Goodwill impairment | |||||
| Stock-based compensation expense | |||||
| Amortization of debt issuance costs | |||||
| Benefit for deferred income taxes | |||||
| Amortization of acquisition-related inventory step-up | |||||
| Forward contract losses, net | |||||
| Other, net | |||||
| (Increase) decrease in, net of acquisition: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Income taxes receivable | |||||
| Other current assets | |||||
| Other assets | |||||
| Increase (decrease) in, net of acquisition: | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Income taxes payable | |||||
| Other noncurrent liabilities | |||||
| Contingent consideration payments in excess of acquisition date fair value | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Business acquisitions, net of cash acquired | |||||
| Capital expenditures | |||||
| Proceeds from dispositions of property, plant and equipment | |||||
| Business Divestiture Proceeds | |||||
| Cash settlement of forward contracts | |||||
| Software development costs | |||||
| Amounts paid for net assets acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings on revolving credit facilities | |||||
| Repayment of borrowings on revolving credit facilities | |||||
| Borrowings on long-term non-revolving debt | |||||
| Repayment of borrowings on long-term non-revolving debt | |||||
| Proceeds from stock issued | |||||
| Purchase of treasury stock | |||||
| Dividends paid to shareholders | |||||
| Payment of employee tax withholding on equity award vestings | |||||
| Payment of contingent consideration liability | |||||
| Proceeds received upon termination of Cash Flow hedge instruments | |||||
| Other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Cash paid: | |||||
| Income taxes | |||||
| Interest | |||||
| Supplemental disclosure of noncash transactions: | |||||
| Unrealized loss (gain) on interest rate swaps | |||||
| Contingent consideration incurred in connection with acquisition | |||||
| Stock issued for acquisition | |||||
| Foreign currency remeasurement impact on euro denominated debt | |||||
| Measurement period adjustment | |||||
| Income taxes paid: | |||||
| Income taxes paid | |||||
| Federal | |||||
| Foreign | |||||
| Italy | |||||
| China | |||||
| Australia | |||||
| All other foreign | |||||
Loading...